XML 63 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss $ (98,171) $ (3,466,331) $ (90,008,006) $ (86,626,099) $ (21,380,138)
Adjustments to reconcile net loss to net cash (used in) operating activities          
Depreciation and amortization   11,212 28,058    
Amortization of intangible assets   79,911 79,911    
Change in inventory reserve   0 12,711    
Stock based compensation   138,532 623,799    
Preferred shares issued for services   300,000 0    
Common stock issued for services   0 2,627,600    
Amortization of debt discount   546,691 1,237,264    
Change in fair value of derivative liability   (1,594,624) 20,259,893    
Expense related to warrant   0 62,500,000    
Accrued interest on convertible notes payable   206,855 141,419    
Loss on class action lawsuit settlements   2,000,000 0    
Excess and obsolete inventory   20,215 0    
Write-off of patent expenses   3,600 0    
Changes in operating assets and liabilities:          
Restricted Cash   0 46,400    
Accounts receivable   0 91,615    
Inventory   427,441 437,493    
Prepaid expenses   41,791 (36,397)    
Other receivable   0 3,340    
Deposits   16,830 9,290    
Accounts payable   391,494 (107,035)    
Accrued expenses   (75,385) 104,314    
Deferred revenue   (58,779) (30,888)    
CASH (USED IN) OPERATING ACTIVITIES   (1,010,547) (1,979,219) (2,122,577) (1,791,074)
CASH FLOWS FROM INVESTING ACTIVITIES:          
Capital expenditures   0 (3,925)    
NET CASH (USED IN) INVESTING ACTIVITIES:   0 (3,925)    
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from the issuance of convertible debt   786,878 350,000    
Proceeds from options exercised   0 44,673    
Payments of notes payable - related party   0 (1,160)    
NET CASH PROVIDED BY FINANCING ACTIVITIES   786,878 393,513    
NET (DECREASE) IN CASH AND CASH EQUIVALENTS   (223,669) (1,589,631)    
CASH AND CASH EQUIVALENTS, beginning of period   286,238 1,831,276 1,831,276  
CASH AND CASH EQUIVALENTS, end of period $ 62,569 62,569 241,645 $ 286,238 $ 1,831,276
Supplemental disclosures of cash flows information:          
Cash paid for interest   10,500 0    
Cash paid for income taxes   0 0    
NON-CASH TRANSACTIONS          
6% Senior secured convertible notes and interest converted into common stock   0 62,025    
7% Convertible notes and interest converted into common stock   0 1,384,207    
12% Senior secured convertible notes and interest converted into common stock   0 439,688    
Common stock issued for cashless exercise of options   0 357    
Common stock issued for conversion of accounts payable   $ 171,000 $ 0